pyridostigmine

Generic: pyridostigmine bromide oral

Labeler: novitium pharma llc
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name pyridostigmine
Generic Name pyridostigmine bromide oral
Labeler novitium pharma llc
Dosage Form SOLUTION
Routes
ORAL
Active Ingredients

pyridostigmine bromide 60 mg/5mL

Manufacturer
Novitium Pharma LLC

Identifiers & Regulatory

Product NDC 70954-148
Product ID 70954-148_ef78ff05-8e0f-463a-88cd-ca9a01aed76a
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA211694
Listing Expiration 2026-12-31
Marketing Start 2019-03-11

Pharmacologic Class

Classes
cholinesterase inhibitor [epc] cholinesterase inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 70954148
Hyphenated Format 70954-148

Supplemental Identifiers

RxCUI
903843
UNII
KVI301NA53

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name pyridostigmine (source: ndc)
Generic Name pyridostigmine bromide oral (source: ndc)
Application Number ANDA211694 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 60 mg/5mL
source: ndc
Packaging
  • 473 mL in 1 BOTTLE (70954-148-10)
source: ndc

Packages (1)

Ingredients (1)

pyridostigmine bromide (60 mg/5mL)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "ef78ff05-8e0f-463a-88cd-ca9a01aed76a", "openfda": {"unii": ["KVI301NA53"], "rxcui": ["903843"], "spl_set_id": ["ef78ff05-8e0f-463a-88cd-ca9a01aed76a"], "manufacturer_name": ["Novitium Pharma LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "473 mL in 1 BOTTLE (70954-148-10)", "package_ndc": "70954-148-10", "marketing_start_date": "20190311"}], "brand_name": "Pyridostigmine", "product_id": "70954-148_ef78ff05-8e0f-463a-88cd-ca9a01aed76a", "dosage_form": "SOLUTION", "pharm_class": ["Cholinesterase Inhibitor [EPC]", "Cholinesterase Inhibitors [MoA]"], "product_ndc": "70954-148", "generic_name": "Pyridostigmine bromide oral", "labeler_name": "Novitium Pharma LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Pyridostigmine", "active_ingredients": [{"name": "PYRIDOSTIGMINE BROMIDE", "strength": "60 mg/5mL"}], "application_number": "ANDA211694", "marketing_category": "ANDA", "marketing_start_date": "20190311", "listing_expiration_date": "20261231"}